$30.56 $0.50 per serving
Product analysis
Complete Omega Lemon offers omega-3, omega-6 and omega-9 together in a lemon option. The oil forms are unspecified, which limits a direct comparison of absorption.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
The oil forms are not clearly declared, leaving absorption difficult to compare. The range of omega fats does not itself establish a quality advantage.
Ingredient Transparency63
The listed amounts are disclosed, helping you compare servings. The oil forms are unspecified, leaving the source details incomplete.
Value For Money63
The omega-6 and omega-9 contributions offer favorable value, while omega-3 offers middling value. The price appeal therefore depends on which fat contribution you want most.
Customer Satisfaction85
Customer feedback is very favorable across a substantial number of ratings. Those ratings describe satisfaction without establishing skin benefits.
Product Focus71
The formula combines several omega fats around a skin-related aim. The skin evidence concerns a specific EPA preparation, so it does not establish a routine skin benefit from this mixed oil.
- Format
Softgel - Container
- 120 Softgel(s)
- Per serving
- $0.50
- Also available
Complete Omega Jr. Lemon$31.41- Customer rating
- 4.8 · 1,463 ratings
Goals
Impact
High effect
Omega-3 · 565 mg
Omega-3 fatty acids are connected with skin lipids, and specific purified EPA preparations have been studied for responses to UV exposure. Those findings do not establish routine skin benefits from this product’s broad omega-3 declaration or a generic fish-oil amount. GLA remains unresolved because the stored label claim lacks a matching ingredient declaration; the stated claim cannot establish a usable amount.
How this product is rated for Skin Health
Ingredient fit83
Omega-3 provides the main relevant connection in this formula. Amounts provide partial coverage of the supplied comparison ranges.
Goal fit
Omega-3 provides a focused connection to the selected skin-health aspects.
Dose adequacy
The 565 mg omega-3 serving receives partial exposure recognition; the unresolved GLA claim does not establish a dose.
Pathways17
The supplied findings connect omega-3 with barrier lipids, although generic omega-3 amounts do not establish a tested skin intervention.
Depth
The strongest connection in the supplied findings is epidermal barrier lipids; this describes a mechanism, not a measured cosmetic result.
Breadth
No mechanism reaches the supplied coverage threshold.
Evidence78
Specific purified EPA has human UV-challenge evidence, but that preparation cannot be inferred from generic omega-3. The supplied preparation finding therefore has limited practical applicability.
Evidence strength
The human UV evidence uses specific purified EPA, so broad omega-3 does not establish the same intervention.
Studied preparation
The supplied preparation criterion is met, but generic omega-3 does not establish the purified EPA composition used in the cited skin research.
Formulation logic100
No required partner is missing and no specified formulation conflict is identified. This does not establish extra benefit from the combination.
Partner coverage
All counted ingredients work without an additional required partner or have that partner present.
Conflicts
No specified formulation conflict was matched in the supplied facts.
Effective doses
All ingredients counted for this finding clear its minimum exposure threshold, without establishing a clinically effective skin dose.
Omega-9 Not classified
No linked studies yet.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calories | 20 Calorie(s) | |
Total Fat | 2 Gram(s) | |
Total Omega-3 Fatty Acids | 565 mg | |
Omega-6 Fatty Acids | 240 mg | |
Omega-9 Fatty Acids | 225 mg |
Omega-9 · 225 mg OverallScore76
Omega-6 · 240 mg OverallScore76
A serving provides 240 mg of omega-6, including 70 mg of gamma-linolenic acid (GLA). The remaining omega-6 and the specific oil source are not identified in the saved facts.
How this ingredient is rated
Active Ingredient Quality & Bioavailability64
GLA is identified at 70 mg per serving, but the saved facts do not name its oil source or identify the remaining omega-6. No extraction method is recorded in the saved facts.
Omega-6 Source & GLA Content
GLA is identified at 70 mg per serving, but the saved facts do not name its oil source or identify the remaining omega-6.
Extraction Method & Purity
No extraction method is recorded in the saved facts.
Dose, Safety & Label Transparency85
A serving contains 240 mg omega-6, including 70 mg of GLA; the remaining fatty acids are not identified in the saved facts.
Omega-6 Potency vs. Median
A serving contains 240 mg of omega-6.
Fatty Acid Profile Transparency
GLA is listed at 70 mg per serving; the rest of the omega-6 is not broken down in the saved facts.
Value80
A whole-product serving costs about $0.51.
Price Per Serving Efficiency
A whole-product serving costs about $0.51.
Omega-3 · 565 mg OverallScore74
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Dietetic intervention in psoriatic arthritis: the DIETA trial.
- Omega-3 fatty acid supplement skin cancer prophylaxis in lung transplant recipients: A randomized, controlled pilot trial.
- Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.
- Treatment of hard-to-heal wounds in ischaemic lower extremities with a novel fish skin-derived matrix.
- Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers.
- Psychosocial Burden in People with Atopic Dermatitis: Effects of a Substance-Free Basic Skincare in a Randomized Health Care Study.
- Abnormalities in epidermal lipid metabolism in patients with atopic dermatitis.
- Maternal plasma phosphatidylcholine fatty acids and atopy and wheeze in the offspring at age of 6 years.
- Plasma omega-3 and omega-6 concentrations and risk of cutaneous basal and squamous cell carcinomas in Australian adults.
- Maternal PUFA status and offspring allergic diseases up to the age of 18 months.